ConductScience.org, home

Library / Trials

Acute Cognitive Effects of Brain Edge

NCT07018674, Not applicable, Completed, Nature's Sunshine Products, Inc.

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleAcute Cognitive Effects of Brain EdgeClinicalTrials.gov
NCT numberNCT07018674ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment50 participants, actualClinicalTrials.gov
Lead sponsorNature's Sunshine Products, Inc.ClinicalTrials.gov
ConditionsCognitive Health, MoodClinicalTrials.gov
InterventionsExperimental, Placebo, WaterClinicalTrials.gov
First posted2025-06-12ClinicalTrials.gov
Last updated2026-04-13ClinicalTrials.gov

Registered outcomes 9

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryNumber of participants with supplementation-related adverse events (AEs) as assessed by Common Terminology Criteria for Adverse Events v4.0 (CTCAE v4.0).7 days after final clinical visit
Data collected at individual study visits will be used to assess participants for any adverse events associated with the study procedures or products. Subjects with ongoing adverse events will be followed until resolution at the discretion of the PI.
ClinicalTrials.gov
SecondaryAttention ShiftingPrior to supplementation (Baseline) and 30 minutes after supplementation (Post) during each of the 3 clinical visits.Assessed by changes in attention shifting score in the Berg-Wisconsin Card Sorting Task Test.ClinicalTrials.gov
SecondaryWorking MemoryPrior to supplementation (Baseline) and 30 minutes after supplementation (Post) during each of the 3 clinical visits.Assessed by changes in score in Sternberg Scanning Task Test.ClinicalTrials.gov
SecondaryReaction TimePrior to supplementation (Baseline) and 30 minutes after supplementation (Post) during each of the 3 clinical visits.Assessed by changes in score in 9-cell reaction test.ClinicalTrials.gov
SecondarySelective AttentionPrior to supplementation (Baseline) and 30 minutes after supplementation (Post) during each of the 3 clinical visits.Assessed by changes in score in Stroop Task Test.ClinicalTrials.gov
SecondaryExecutive FunctionPrior to supplementation (Baseline) and 30 minutes after supplementation (Post) during each of the 3 clinical visits.Assessed by a change in scores in a simple mathematics testClinicalTrials.gov
SecondaryVisual ProcessingPrior to supplementation (Baseline) and 30 minutes after supplementation (Post) during each of the 3 clinical visits.Assessed by score in Matrix Rotation TestClinicalTrials.gov
SecondaryGaming PerformancePrior to supplementation (Baseline) and 60 minutes after supplementation (Post) during each of the 3 clinical visits.Assessed by score changes in Beat Saber (Virtual Reality Rhythm game).ClinicalTrials.gov
SecondarySubjective Mood and Emotional StatePrior to Supplementation (Baseline), 30 minutes after supplementation (Midpoint) and approximately 90 minutes after supplementation (Post) on each of the 3 clinical visits.Assessed by relative changes in scored survey question results.ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 2

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Card Sorting Test (Berg)Secondary outcomeConductCognition
Stroop Color-Word TestSecondary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)